Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Directors’ Dealings News: Rubean AG (EQS) +++ RUBEAN Aktie +3,13%

CHEMOURS Aktie

 >CHEMOURS Aktienkurs 
15.53 EUR    -10.4%    (TradegateBSX)
Ask: 16.02 EUR / 206 Stück
Bid: 15.525 EUR / 213 Stück
Tagesumsatz: 38 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
CHEMOURS Aktie über LYNX handeln
>CHEMOURS Performance
1 Woche: +1,8%
1 Monat: +33,4%
3 Monate: +88,9%
6 Monate: +35,9%
1 Jahr: +6,0%
laufendes Jahr: +72,3%
>CHEMOURS Aktie
Name:  CHEMOURS CO. DL-,01
Land:  USA
Sektor:  Chemie
ISIN/ Wkn:  US1638511089 / A14RPH
Symbol/ Ticker:  2CU (Frankfurt) / CC (NYSE)
Kürzel:  FRA:2CU, ETR:2CU, 2CU:GR, NYSE:CC
Index:  -
Webseite:  https://www.chemours.com/
Profil:  Chemours Co. is a leading global provider of performance chemicals named after its predecessor, E. I. du Pont de Nemours and Company. The company focuses primarily on manufacturing a wide array of che..
>Volltext..
Marktkapitalisierung:  2599.56 Mio. EUR
Unternehmenswert:  5846.12 Mio. EUR
Umsatz:  4962.83 Mio. EUR
EBITDA:  603.45 Mio. EUR
Nettogewinn:  -281.44 Mio. EUR
Gewinn je Aktie:  -1.87 EUR
Schulden:  3731.42 Mio. EUR
Liquide Mittel:  518.09 Mio. EUR
Operativer Cashflow:  223.97 Mio. EUR
Bargeldquote:  0.33
Umsatzwachstum:  -3.1%
Gewinnwachstum:  -557.92%
Dividende je Aktie:  0.44 EUR
Dividendenrendite:  2.5%
Dividendenschätzung:  1.71%
Div. Historie:  14.11.25 - 0.07508375€
15.08.25 - 0.075075€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  CHEMOURS
Letzte Datenerhebung:  20.02.26
>CHEMOURS Kennzahlen
Aktien/ Unternehmen:
Aktien: 149.89 Mio. St.
Frei handelbar: 99.27%
Rückkaufquote: -0.03%
Mitarbeiter: 6000
Umsatz/Mitarb.: 0.81 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: -18.31%
Bewertung:
KGV: -
KGV lG: 20.79
KUV: 0.53
KBV: 10.11
PEG-Ratio: -
EV/EBITDA: 9.69
Rentabilität:
Bruttomarge: 17.39%
Gewinnmarge: -5.67%
Operative Marge: 6.42%
Managementeffizenz:
Gesamtkaprendite: -4.43%
Eigenkaprendite: -69.74%
>CHEMOURS Peer Group
Chemie, Lacke, Farben & Pigmente
 
20.02.26 - 02:30
Compared to Estimates, Chemours (CC) Q4 Earnings: A Look at Key Metrics (Zacks)
 
While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....
20.02.26 - 01:45
Chemours (CC) Beats Q4 Earnings Estimates (Zacks)
 
Chemours (CC) delivered earnings and revenue surprises of +2,400.00% and 0.00%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...
19.02.26 - 23:15
Chemours misses Q4 estimates as APM headwinds weigh; Shares plunge 10% (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
19.02.26 - 22:42
Chemours Non-GAAP EPS of $0.05 beats by $0.03, revenue of $1.33B in-line (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
19.02.26 - 22:39
The Chemours Company Reports Fourth Quarter and Full Year 2025 Results (PR Newswire)
 
WILMINGTON, Del., Feb. 19, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced Performance Materials ("APM"),......
17.02.26 - 22:36
Chemours declares $0.0875 dividend (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
17.02.26 - 22:33
Chemours Announces First Quarter Dividend (PR Newswire)
 
WILMINGTON, Del., Feb. 17, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the first quarter of 2026. The dividend will be......
17.02.26 - 16:45
Curious about Chemours (CC) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
 
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Chemours (CC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025....
04.02.26 - 22:33
Chemours Announces Dates for Fourth Quarter 2025 Earnings Release and Webcast Conference Call (PR Newswire)
 
WILMINGTON, Del., Feb. 4, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC) today announced that the Company expects to issue its fourth quarter 2025 financial results after market on Thursday, February 19, 2026. The Company expects to hold its conference......
16.01.26 - 05:51
Chemours to sell former titanium dioxide site in Taiwan (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
15.01.26 - 23:03
The Chemours Company Agrees to Sell Former Titanium Dioxide Site in Taiwan (PR Newswire)
 
WILMINGTON, Del., Jan. 15, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced Performance Materials ("APM"),......
13.01.26 - 14:42
Chemours: A New Year Perspective: Trusted Chemistry (Accesswire)
 
By Denise Dignam, President & CEO, Chemours NORTHAMPTON, MA / ACCESS Newswire / January 13, 2026 / When I look back on the year we just completed, what stands out most isn't a single milestone-it's......
22.12.25 - 20:00
This Chemicals Stock Is Down 32% but Just Became a Top 5 Holding After One Fund′s $13 Million Bet (Fool)
 
Here's why one New York fund just scooped up 800,000 shares of The Chemours Company....
04.12.25 - 22:33
Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel (Business Wire)
 
WILMINGTON, Del.--(BUSINESS WIRE)--$CC--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, today announced the appointment of Michael Foley as President of Chemours Titanium Technologies (TT), effective February 2026. Foley succeeds Damián Gumpel, who is departing the company. Chemours thanks Mr. Gumpel for his contributions and wishes him well in his future endeavors. This transition reflects Chemours' ongoing commitment to advancing its TT value-based business strategy. During this period, Chemours President and CEO Denise Dignam will provide leadership support to ensure continuity and continued progress on TT's transformation journey. Michael Foley joins Chemours with extensive leadership experience in the chemical industry. Most recently, he served as President & General Manager of the Formulated Specialties Business at Momentive Performance Material...
02.12.25 - 14:42
Chemours′ Approach to Circularity (Accesswire)
 
NORTHAMPTON, MA / ACCESS Newswire / December 2, 2025 / Chemours:With the refresh of Chemours' Corporate Responsibility Commitment 2030 goals, we are sharpening our focus and helping to build a more......
30.11.25 - 22:12
This Fund Bought $63 Million of Chemours Stock Even as Shares Sit 80% Below 2017 Highs (Fool)
 
One hedge fund just made a bold bet on a beaten-down chemicals giant—here's what long-term investors should know....
11.11.25 - 14:31
Chemours Q3 Earnings Lag Estimates Amid Operational Disruptions (Zacks)
 
CC posts a Q3 profit rebound with $60M in net income, driven by strong Thermal & Specialized Solutions amid mixed segment results....
07.11.25 - 17:51
Chemours anticipates double-digit Opteon growth and $5.7B–$5.8B sales in 2025 as TSS segment outpaces expectations (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.11.25 - 15:30
Chemours-Aktie fällt nach Verfehlung der Gewinnprognose für Q3 2025/n (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
07.11.25 - 02:30
Chemours (CC) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
 
The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Man glaubt gar nicht, wie schwer es oft ist, eine Tat in einen Gedanken umzusetzen! - Karl Kraus
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!